{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:29:07Z","timestamp":1786980547903,"version":"build-2736575974"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Public Health Research Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s10147-016-1069-7","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T03:22:00Z","timestamp":1480562520000},"page":"405-412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Breakthrough chemotherapy-induced nausea and vomiting: report of a nationwide survey by the CINV Study Group of Japan"],"prefix":"10.1007","volume":"22","author":[{"name":"The CINV Study Group of Japan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2720-9774","authenticated-orcid":false,"given":"Kazuo","family":"Tamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Aiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiharu","family":"Kamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Maehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mototsugu","family":"Shimokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Kitajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,1]]},"reference":[{"key":"1069_CR1","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s10147-015-0786-7","volume":"20","author":"Tamura K, Aiba K, Saeki T, CINV Study Group of Japan et al","year":"2015","unstructured":"Tamura K, Aiba K, Saeki T, CINV Study Group of Japan et al (2015) Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan. Int J Clin Oncol 20:855\u2013865","journal-title":"Int J Clin Oncol"},{"key":"1069_CR2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/cncr.10630","volume":"95","author":"N Carelle","year":"2002","unstructured":"Carelle N, Piotto E, Bellanger A et al (2002) Changing patient perceptions of the side effects of cancer chemotherapy. Cancer (Phila) 95:155\u2013163","journal-title":"Cancer (Phila)"},{"issue":"suppl 5","key":"1069_CR3","doi-asserted-by":"crossref","first-page":"v232","DOI":"10.1093\/annonc\/mdq194","volume":"21","author":"F Roila","year":"2010","unstructured":"Roila F, Herrstedt J, Aapro M et al (2010) Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol 21(suppl 5):v232\u2013v243","journal-title":"Ann Oncol"},{"key":"1069_CR4","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.2010.34.4614","volume":"29","author":"E Basch","year":"2011","unstructured":"Basch E, Prestrud AA, Hesketh PJ et al (2011) Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 29:4189\u20134198","journal-title":"J Clin Oncol"},{"key":"1069_CR5","unstructured":"National Comprehensive Cancer Network (2016) Antiemesis. In: NCCN clinical practice guidelines in oncology version 2. 2016. Available via the National Comprehensive Cancer Network. http:\/\/www.nccn.org\/ . Accessed 28 June 2016"},{"key":"1069_CR6","volume-title":"Guidelines for appropriate use of antiemetic drugs, version 1 (in Japanese)","author":"Japan Society of Clinical Oncology","year":"2010","unstructured":"Japan Society of Clinical Oncology (2010) Guidelines for appropriate use of antiemetic drugs, version 1 (in Japanese). Kanehara, Tokyo"},{"key":"1069_CR7","volume-title":"Guidelines for appropriate use of antiemetic drugs, version 1 (in Japanese)","author":"Japan Society of Clinical Oncology","year":"2015","unstructured":"Japan Society of Clinical Oncology (2015) Guidelines for appropriate use of antiemetic drugs, version 1 (in Japanese). Kanehara, Tokyo"},{"key":"1069_CR8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0277-5379(83)90418-2","volume":"19","author":"A Coates","year":"1983","unstructured":"Coates A, Abraham S, Kaye SB et al (1983) On the receiving end: patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 19:203\u2013208","journal-title":"Eur J Cancer Clin Oncol"},{"key":"1069_CR9","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s00520-004-0629-y","volume":"12","author":"P Glare","year":"2004","unstructured":"Glare P, Pereira G, Kristjanson LJ et al (2004) Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer. Support Care Cancer 12:432\u2013440","journal-title":"Support Care Cancer"},{"key":"1069_CR10","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1054\/bjoc.2001.2045","volume":"85","author":"R Wit de","year":"2001","unstructured":"de Wit R, de Boer AC, vd Linden GH et al (2001) Effective cross-over to granisetron after failure to ondansetron, a randomized double blind study in patients failing ondansetron plus dexamethasone during the first 24 hours following highly emetogenic chemotherapy. Br J Cancer 85:1099\u20131101","journal-title":"Br J Cancer"},{"key":"1069_CR11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00520-008-0510-5","volume":"17","author":"M Musso","year":"2009","unstructured":"Musso M, Scalone R, Bonanno V et al (2009) Palonosetron (Aloxi) and dexamethasone for the prevention of acute and delayed nausea and vomiting in patients receiving multiple-day chemotherapy. Support Care Cancer 17:205\u2013209","journal-title":"Support Care Cancer"},{"key":"1069_CR12","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s00520-014-2179-2","volume":"22","author":"Y Ikari","year":"2014","unstructured":"Ikari Y, Ogata K, Nakashima Y et al (2014) Safety and pharmacokinetic evaluation of repeated intravenous administration of palonosetron 0.75 mg in patients receiving highly or moderately emetogenic chemotherapy. Support Care Cancer 22:1959\u20131964","journal-title":"Support Care Cancer"},{"key":"1069_CR13","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s00520-012-1710-6","volume":"21","author":"RM Navari","year":"2013","unstructured":"Navari RM, Nagy CK, Gray SE (2013) The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy. Support Care Cancer 21:1655\u20131663","journal-title":"Support Care Cancer"},{"key":"1069_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/956785","author":"M Abe","year":"2015","unstructured":"Abe M, Kasamatsu Y, Kado N et al (2015) Efficacy of olanzapine combined therapy for patients receiving highly emetogenic chemotherapy resistant to standard antiemetic therapy. Biomed Res Int. doi: 10.1155\/2015\/956785","journal-title":"Biomed Res Int"},{"key":"1069_CR15","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1007\/s00520-016-3075-8","volume":"24","author":"L Chiu","year":"2016","unstructured":"Chiu L, Chow R, Popovic M et al (2016) Efficacy of olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting (CINV): a systemic review and meta-analysis. Support Care Cancer 24:2381\u20132392","journal-title":"Support Care Cancer"},{"key":"1069_CR16","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/cncr.20230","volume":"100","author":"SM Grunberg","year":"2004","unstructured":"Grunberg SM, Deuson RR, Mavros P et al (2004) Incidence of chemotherapy-induced nausea and emesis after modern antiemetics. Cancer (Phila) 100:2261\u20132268","journal-title":"Cancer (Phila)"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-016-1069-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-016-1069-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-016-1069-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T00:57:51Z","timestamp":1498352271000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-016-1069-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,1]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["1069"],"URL":"https:\/\/doi.org\/10.1007\/s10147-016-1069-7","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,1]]}}}